Skip to main content

Table 1 Patient demographics and characteristics at study entry

From: Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain

Characteristics

Safety population

Hong Kong

(n = 26)

Korea

(n = 62)

Philippines

(n = 26)

All

(n = 114)

Age (years), mean (SD)

55.2 (7.7)

55.6 (15.5)

62.2 (11.3)

57.0 (13.4)

Gender, n (%)

 Male

8 (30.8)

16 (25.8)

4 (15.4)

28 (24.6)

 Female

18 (69.2)

46 (74.2)

22 (84.6)

86 (75.4)

Causes of pain, n (%)

 Osteoarthritis

6 (23.1)

29 (46.8)

20 (76.9)

55 (48.3)

 Rheumatoid arthritis

6 (23.1)

0 (0.0)

2 (7.7)

8 (7.0)

 Low back pain

9 (34.6)

32 (51.6)

2 (7.7)

43 (37.7)

 Joint or muscle pain

5 (19.2)

1 (1.6)

2 (7.7)

8 (7.0)

aConcomitant illnesses, n (%)

 Yes

25 (96.2)

48 (77.4)

20 (76.9)

93 (81.6)

 No

1 (3.8)

14 (22.6)

6 (23.1)

21 (18.4)

  1. SD standard deviation
  2. aConcomitant illness was defined as any medical condition, other than the primary condition, that occurred within the last five years prior to study entry or during the course of the study